Evidence map›Paper›PMID 34011619›Full record

ArticleJournal of clinical pathology2021

Nuclear-specific accumulation of

L Samuel Hellgren, Ann Olsson, Ann Kaufeldt, Johan O Paulsson, Martin Hysek, Adam Stenman, Jan Zedenius, Catharina Larsson, Anders Höög, C Christofer Juhlin

Open access · hybridAbstract read
In one paragraph

Article in Journal of clinical pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. 5hmC Immunohistochemistry: A Predictor ofThe journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

L Samuel HellgrenDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Ann OlssonDepartment of Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden.
Ann KaufeldtDepartment of Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden.
Johan O PaulssonDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Martin HysekDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Adam StenmanDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Jan ZedeniusDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Catharina LarssonDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Anders HöögDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
C Christofer JuhlinDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden christofer.juhlin@ki.se.ORCID http://orcid.org/0000-0002-5945-9081
Karolinska University Hospital · SEKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsUpregulation of the

methodsWe collected formalin-fixated paraffin-embedded tissues from 26 follicular thyroid tumours; 7 FTCs, 2 follicular thyroid tumours of uncertain malignant potential (FT-UMPs) and a single Hürthle cell carcinoma with established

results

conclusions

Indexed as

in situ hybridizationmolecularpathologythyroid neoplasms

Identifiers

PMID34011619
PMCPMC9510436
OpenAlexW3160900407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.